Longitude Capital Partners II, LLC
Related Filers (14)
- Longitude Venture Partners II, L.P. (14)
- Tammenoms Bakker Juliet (13)
- ENRIGHT PATRICK G (11)
- Aimmune Therapeutics, Inc. (10)
- KALA BIO, Inc. (7)
- Aptinyx Inc. (6)
- RAPID MICRO BIOSYSTEMS, INC. (4)
- Tricida, Inc. (3)
- Venus Concept Inc. (3)
- RxSight, Inc. (3)
- Nabriva Therapeutics plc (2)
- Vaxcyte, Inc. (2)
- Longitude Prime Partners, LLC (1)
- Longitude Prime Fund, L.P. (1)
- Show More ...
Ownership (40)
SC 13D/A
Wednesday, 10/18/2023
KALA BIO, Inc.: Major Shareholders
SC 13D/A
Friday, 8/18/2023
RxSight, Inc.: Major Shareholders
SC 13D/A
Monday, 6/5/2023
RxSight, Inc.: Major Shareholders
SC 13D/A
Thursday, 3/16/2023
Aptinyx Inc.: Major Shareholders
SC 13D/A
Tuesday, 2/14/2023
Aptinyx Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
RAPID MICRO BIOSYSTEMS, INC.: Major Shareholders
SC 13D/A
Tuesday, 2/14/2023
Kala Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Tuesday, 1/3/2023
Venus Concept Inc.: Major Shareholders
SC 13G
Tuesday, 2/15/2022
RAPID MICRO BIOSYSTEMS, INC.: Major Shareholders
SC 13D
Friday, 8/13/2021
RxSight, Inc.: Major Shareholders
4
Tuesday, 7/20/2021
RAPID MICRO BIOSYSTEMS, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/14/2021
RAPID MICRO BIOSYSTEMS, INC.: Initial statement of beneficial ownership of securities
SC 13G
Friday, 2/12/2021
Vaxcyte, Inc.: Major Shareholders
3
Thursday, 6/11/2020
Vaxcyte, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Monday, 3/23/2020
Kala Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/12/2020
Nabriva Therapeutics plc: Major Shareholders
SC 13D/A
Wednesday, 2/12/2020
Aptinyx Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/12/2020
Aimmune Therapeutics, Inc.: Major Shareholders
SC 13D
Monday, 11/18/2019
Venus Concept Inc.: Major Shareholders
3
Thursday, 11/7/2019
Venus Concept Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/12/2019
Aimmune Therapeutics, Inc.: Major Shareholders
SC 13D
Friday, 10/12/2018
Kala Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Tuesday, 8/7/2018
Nabriva Therapeutics plc: Major Shareholders
SC 13D
Friday, 7/6/2018
Tricida, Inc.: Major Shareholders
SC 13D
Monday, 7/2/2018
Aptinyx Inc.: Major Shareholders
4
Monday, 7/2/2018
Tricida, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/27/2018
Tricida, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/26/2018
Aptinyx Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/20/2018
Aptinyx Inc.: Initial statement of beneficial ownership of securities
SC 13G
Monday, 2/12/2018
Kala Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Monday, 2/12/2018
Aimmune Therapeutics, Inc.: Major Shareholders
4
Thursday, 7/27/2017
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/19/2017
Kala Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/21/2017
Aimmune Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/10/2017
Aimmune Therapeutics, Inc.: Major Shareholders
4
Thursday, 12/1/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/31/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 1/29/2016
Aimmune Therapeutics, Inc.: Major Shareholders
4
Tuesday, 8/11/2015
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/5/2015
Aimmune Therapeutics, Inc.: Initial statement of beneficial ownership of securities